Peter Messiaen
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- COVID-19 Clinical Research Studies
Papers in
-
- HIV/AIDS drug development and treatment 8
- HIV/AIDS Research and Interventions 5
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 and COVID-19 Research 2
-
- Sepsis Diagnosis and Treatment 2
- Co-authors
- Jeroen C.H. van der Hilst (15 shared papers)Linos Vandekerckhove (10 shared papers)Steven Vanderschueren (2 shared papers)Michel Moutschen (2 shared papers)Inge C. Gyssens (9 shared papers)Bernard Lauwerys (1 shared paper)Nele Brusselaers (1 shared paper)Axel Fun (1 shared paper)
- Journals
- Journal of the International AIDS Society (3 papers)HIV Medicine (3 papers)PLoS ONE (2 papers)BMC Infectious Diseases (2 papers)Thrombosis Research (1 paper)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Peter Messiaen
36 papers receiving 634 citations
Peers
Comparison fields: 5 of 83
- Virology 135
- Infectious Diseases 290
- Emergency Medicine 40
- Applied Microbiology and Biotechnology 8
- Epidemiology 102
Countries citing papers authored by Peter Messiaen
This map shows the geographic impact of Peter Messiaen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Messiaen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Messiaen more than expected).
Fields of papers citing papers by Peter Messiaen
This network shows the impact of papers produced by Peter Messiaen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Messiaen. The network helps show where Peter Messiaen may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Messiaen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 83 | |
| 2 | 2016 | 73 | |
| 3 | 2021 | 49 | |
| 4 | 2020 | 48 | |
| 5 | 2012 | 41 | |
| 6 | 2016 | 36 | |
| 7 | 2014 | 33 | |
| 8 | 2016 | 29 | |
| 9 | 2020 | 25 | |
| 10 | Prevalence of drug-drug interactions in the era of HIV integrase inhibitors: a retrospective clinical study. | 2017 | 23 |
| 11 | 2014 | 21 | |
| 12 | 2015 | 18 | |
| 13 | 2023 | 15 | |
| 14 | 2020 | 11 | |
| 15 | 2020 | 10 | |
| 16 | 2012 | 10 | |
| 17 | 2023 | 9 | |
| 18 | 2022 | 9 | |
| 19 | 2023 | 8 | |
| 20 | 2022 | 8 |
About Peter Messiaen
Peter Messiaen is a scholar working on Infectious Diseases, Epidemiology, Virology, Surgery and Neurology, having authored 39 papers that have together received 642 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (5 papers), COVID-19 Clinical Research Studies (5 papers), Long-Term Effects of COVID-19 (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Sepsis Diagnosis and Treatment (2 papers) and Parasites and Host Interactions (2 papers). The work is most often cited by research in Virology (135 citations), Infectious Diseases (290 citations), Emergency Medicine (40 citations), Applied Microbiology and Biotechnology (8 citations) and Epidemiology (102 citations). Peter Messiaen has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Jeroen C.H. van der Hilst, Linos Vandekerckhove, Steven Vanderschueren, Michel Moutschen, Inge C. Gyssens, Bernard Lauwerys, Nele Brusselaers, Axel Fun, Annemarie M. J. Wensing and Monique Nijhuis. Their work appears in journals such as Journal of the International AIDS Society, HIV Medicine, PLoS ONE, BMC Infectious Diseases and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.